Replimune Group, Inc. (REPL)
7.965
-0.02
(-0.19%)
USD |
NASDAQ |
Feb 13, 16:00
7.965
0.00 (0.00%)
After-Hours: 17:29
Replimune Group Free Cash Flow : -283.27M for Dec. 31, 2025
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| CorMedix, Inc. | 74.42M |
| Verastem, Inc. | -140.93M |
| Sarepta Therapeutics, Inc. | -401.63M |
| Anavex Life Sciences Corp. | -34.08M |
| Ocugen, Inc. | -53.53M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -65.96M |
| Cash from Investing (Quarterly) | 75.12M |
| Cash from Financing (Quarterly) | 10.45M |
| Free Cash Flow Per Share (Quarterly) | -0.7169 |
| Free Cash Flow to Equity (Quarterly) | -66.11M |
| Free Cash Flow to Firm (Quarterly) | -64.13M |
| Free Cash Flow Yield | -40.33% |